Aurinia Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	260.11	235.13	175.51	134.03	45.61	50.12	Upgrade
Revenue Growth (YoY)	25.59%	33.97%	30.95%	193.89%	-9.01%	15660.38%	Upgrade
Cost of Revenue	51.61	49.03	63.79	50.65	52.23	50.33	Upgrade
Gross Profit	208.51	186.1	111.72	83.38	-6.63	-0.21	Upgrade
Selling, General & Admin	125.76	172.03	195.04	196.37	173.54	97.27	Upgrade
Other Operating Expenses	19.64	1.55	2.48	-1.52	0.57	6.81	Upgrade
Operating Expenses	145.4	173.58	197.52	194.85	174.11	104.08	Upgrade
Operating Income	63.11	12.52	-85.79	-111.47	-180.74	-104.29	Upgrade
Interest Expense	-4.54	-4.84	-2.78	-	-	-	Upgrade
Interest & Investment Income	15.01	16.97	17	5.12	0.53	1.52	Upgrade
Currency Exchange Gain (Loss)	5.9	5.9	-5.9	-	-	-	Upgrade
EBT Excluding Unusual Items	79.48	30.55	-77.47	-106.35	-180.21	-102.77	Upgrade
Merger & Restructuring Charges	-17	-23.11	-	-	-	-	Upgrade
Pretax Income	62.49	7.45	-77.47	-106.35	-180.21	-102.77	Upgrade
Income Tax Expense	1.85	1.7	0.55	1.83	0.76	-0.09	Upgrade
Net Income	60.64	5.75	-78.02	-108.18	-180.97	-102.68	Upgrade
Net Income to Common	60.64	5.75	-78.02	-108.18	-180.97	-102.68	Upgrade
Shares Outstanding (Basic)	140	143	143	142	129	118	Upgrade
Shares Outstanding (Diluted)	145	146	143	142	129	118	Upgrade
Shares Change (YoY)	0.70%	2.07%	0.93%	9.70%	9.20%	27.36%	Upgrade
EPS (Basic)	0.43	0.04	-0.54	-0.76	-1.40	-0.87	Upgrade
EPS (Diluted)	0.42	0.04	-0.54	-0.76	-1.40	-0.87	Upgrade
Free Cash Flow	92.43	44.11	-34.18	-79.82	-158	-75.53	Upgrade
Free Cash Flow Per Share	0.64	0.30	-0.24	-0.56	-1.22	-0.64	Upgrade
Gross Margin	80.16%	79.15%	63.66%	62.21%	-14.53%	-0.42%	Upgrade
Operating Margin	24.26%	5.32%	-48.88%	-83.17%	-396.31%	-208.09%	Upgrade
Profit Margin	23.31%	2.45%	-44.45%	-80.71%	-396.81%	-204.88%	Upgrade
Free Cash Flow Margin	35.53%	18.76%	-19.47%	-59.55%	-346.44%	-150.70%	Upgrade
EBITDA	82.58	31.96	-74.14	-108.76	-177.97	-102.92	Upgrade
EBITDA Margin	31.75%	13.59%	-42.24%	-81.15%	-	-205.35%	Upgrade
D&A For EBITDA	19.48	19.45	11.65	2.71	2.76	1.37	Upgrade
EBIT	63.11	12.52	-85.79	-111.47	-180.74	-104.29	Upgrade
EBIT Margin	24.26%	5.32%	-48.88%	-83.17%	-	-208.09%	Upgrade
Effective Tax Rate	2.96%	22.77%	-	-	-	-	Upgrade
Revenue as Reported	260.11	235.13	175.51	134.03	45.61	50.12	Upgrade

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q